Marine Harvest ASA – Mandatory notification of trade
Framar AS (Framar), a company controlled by Marine Harvest ASA’s (Marine Harvest) Chairman Ole-Eirik Lerøy, and Sterna Finance Ltd (Sterna), […]
GW4, the Met Office, and Cray Power Up the Largest Arm-Based Supercomputer in Europe
“Isambard” Supercomputer to Be Used for Scientific Research and Building the Next Generation of Computing Technology in the Exascale Era […]
New Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patients
Entresto® (sacubitril/valsartan) outperformed commonly used heart failure medicine enalapril in landmark study; delivered significantly greater and more rapid reductions in […]
Corvus Pharmaceuticals Announces Updated Results from Ongoing Clinical Studies of Lead Programs, CPI-444 and CPI-006, at SITC 33rd Annual Meeting
CPI-444 demonstrated prolonged survival in patients with refractory renal cell carcinoma both as a monotherapy and in combination with atezolizumab […]
Vascepa® (icosapent ethyl) 26% Reduction in Key Secondary Composite Endpoint of Cardiovascular Death, Heart Attacks and Stroke Demonstrated in REDUCE-IT™ Supports 25% Overall Reduction in Five-Point Major Adverse Cardiovascular Event Primary Composite Endpoint
Landmark Cardiovascular Risk Reduction Benefits Demonstrated in REDUCE-IT Are Largest of Any Major Cardiovascular Outcomes Study of a Drug Intended […]
Jounce Therapeutics Presents Reverse Translational, Biomarker and Preclinical Data from ICOS Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
– Characterization of emerging ICOS hi CD4 T cells from responding patients provides rationale for JTX-2011 combination therapies – CAMBRIDGE, […]
Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in Symptomatic Patients with Mutant or Wild-Type TTR Amyloid Cardiomyopathy
AG10 Was Well Tolerated in Subjects Administered 400 mg or 800 mg Twice Daily for 28 Days AG10 Resulted in […]
Esperion Announces Late-Breaking Oral Presentation of Final Study 3 Results (1002-046) of Bempedoic Acid at the American Heart Association Scientific Sessions 2018
ANN ARBOR, Mich., Nov. 10, 2018 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR), today announced that the final Phase 3 results from […]
Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
Antibody technology provides an exciting new approach to enhance innate immune function in cancer HAMPTON, N.J., Nov. 10, 2018 (GLOBE […]
TSX News -
The Keg Royalties Income Fund announces November 2018 cash distribution
VANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) today announced […]
